Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

At the same time, Benevolent AI identified six compounds, from which baricitinib looked to be the best of the group for both safety and efficacy against SARS-CoV-2. Interestingly, in both cases ...

As of January 2024, changes have been made to our COVID-19 Resource Centre. A COVID-19 Collection is available where you can continue to explore and access The Lancet Group's COVID-19 research, ...